Colorectal Neoplasms
"Colorectal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Descriptor ID |
D015179
|
| MeSH Number(s) |
C04.588.274.476.411.307 C06.301.371.411.307 C06.405.249.411.307 C06.405.469.158.356 C06.405.469.491.307 C06.405.469.860.180
|
| Concept/Terms |
Colorectal Neoplasms- Colorectal Neoplasms
- Neoplasms, Colorectal
- Colorectal Neoplasm
- Neoplasm, Colorectal
- Colorectal Tumors
- Colorectal Tumor
- Tumor, Colorectal
- Tumors, Colorectal
Colorectal Carcinoma- Colorectal Carcinoma
- Carcinoma, Colorectal
- Carcinomas, Colorectal
- Colorectal Carcinomas
Colorectal Cancer- Colorectal Cancer
- Cancer, Colorectal
- Cancers, Colorectal
- Colorectal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Colorectal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Colorectal Neoplasms".
This graph shows the total number of publications written about "Colorectal Neoplasms" by people in this website by year, and whether "Colorectal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2003 | 4 | 3 | 7 | | 2004 | 2 | 1 | 3 | | 2005 | 7 | 0 | 7 | | 2006 | 5 | 3 | 8 | | 2007 | 12 | 2 | 14 | | 2008 | 13 | 4 | 17 | | 2009 | 15 | 0 | 15 | | 2010 | 19 | 3 | 22 | | 2011 | 20 | 2 | 22 | | 2012 | 14 | 6 | 20 | | 2013 | 24 | 7 | 31 | | 2014 | 25 | 2 | 27 | | 2015 | 19 | 2 | 21 | | 2016 | 22 | 4 | 26 | | 2017 | 21 | 3 | 24 | | 2018 | 25 | 7 | 32 | | 2019 | 24 | 5 | 29 | | 2020 | 38 | 4 | 42 | | 2021 | 43 | 2 | 45 | | 2022 | 47 | 1 | 48 | | 2023 | 22 | 1 | 23 | | 2024 | 27 | 5 | 32 | | 2025 | 46 | 1 | 47 | | 2026 | 12 | 1 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Colorectal Neoplasms" by people in Profiles.
-
Duval H, Toomey B, Karam M, Braun T, Fournier D, Grant C, Fairfield H, Chepurko V, Chepurko E, Schimelman A, Nestor B, Ryzhov S, Lindner V, Reagan MR. Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer. Oncotarget. 2026 May 20; 17(1):258-267.
-
Ahmed M, Haneefa SM, Alam A, Kali SK, Al-Sbiei A, Bashir G, Al-Bawardi A, Idriss I, Mohamed YA, Khlaifat B, Naser HT, Labania L, Hamoudi R, Kishore U, Attoub S, Rincon M, Ramadi KB, Fernandez-Cabezudo MJ, Al-Ramadi BK. Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J protein. Mol Biomed. 2026 May 11; 7(1).
-
Wong EYT, Damle SR, Shiu KK, Cohen SA, Lieu CH. Immunotherapy in Localized Colorectal Cancer: Current Practice and Future Directions. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520600.
-
Gohil S, Omar M, Karlitz J, Young P, Greene M. Multi-target stool DNA test adherence among individuals screened for colorectal cancer through the US Defense Health Agency. Curr Med Res Opin. 2026 Feb; 42(2):195-203.
-
Peng C, Catalano P, Zalcberg J, Thor AD, Weiner LM, Khandekar JD, Cohen D, Weinshel EL, O'Dwyer PJ, Benson AB. ECOG-ACRIN E6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer. Oncologist. 2026 Apr 10; 31(5).
-
Abaev-Schneiderman E, Nguyen L, Shalev R, Biton TE, Chopra A, Jagadeesan G, Sevilla-Sanchez D, Tickotsky Moskovitz N, Levin L, Feldman M, Van Rechem C, Levy D. ACTB methylation regulates SMARCA4 genomic occupancy to promote translation and reduce adhesion in colorectal cancer cells. Genome Res. 2026 04 07; 36(4):684-694.
-
Greene M, Camardo M, Karlitz JJ, Nowd P, Wang W, Anderson J, Kisiel J, Ebner D. Real-world adherence to multi-target stool DNA testing and its association with time to follow-up colonoscopy: a health-system analysis from Massachusetts General Hospital. Curr Med Res Opin. 2026 Feb; 42(2):205-219.
-
Müller S, Hendricks A, Uttinger K, Kostatin M, Brüggemann M, Schrader M, Polat B, Flemming S, Lock JF, Germer CT, Wiegering A, Pession U. Brain metastases from colorectal cancer - a retrospective dual center study. J Neurooncol. 2026 Mar 24; 177(2).
-
Faseh L, Fruhling P, Taflin H, Lundmark Rystedt J, Williamsson C, Hemmingsson O, Björnsson B, Gerling M, Sparrelid E, Sandström P, Hasselgren K, Engstrand J. Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer - a national cohort study. Acta Oncol. 2026 Mar 12; 65:201-212.
-
Fountzilas C, Rosario S, Witkiewicz AK, Withers HG, Bajor DL, Mukherjee S, Saltzman J, Maguire O, Minderman H, Chatley S, Tarquini ML, Whitworth A, Jurcevic J, Hsiao HH, Knudsen ES, Muhitch JB, Abrams SI, Kalinski P, Segal BH, Bakin A, Yuan G, Wang C, Attwood K, Iyer R, Boland PM. TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab. Int J Cancer. 2026 Jun 15; 158(12):3300-3311.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|